TOKYO (Reuters) - Japanese pharmaceuticals company KM Biologics Co has already seen overseas interest in its monkeypox vaccine which was recently appr.
A new monkeypox vaccine, manufactured by KM Biologics Co, a Japanese pharmaceutical company, is garnering overseas interest as the disease spreads around the globe.
/PRNewswire/ The "Nonalcoholic Beverages: Global Markets" report has been added to ResearchAndMarkets.com s offering. This report studies the global market.
As health authorities all over the globe search for ways to stop the monkeypox outbreak, investors are snapping up shares of companies that could benefit
Report Scope: The report will provide an updated review of the global probiotics market, focusing on its genus, function, end-use, application, and sales.